Primus News on Nostr: SEC Charges Kiromic BioPharma and Two Former C-Suite Executives with Misleading ...
Published at
2024-12-03 14:59:09Event JSON
{
"id": "a662d290f75d36b97e2c7f3bca58c0cc9a40cca8a49ea0a41a6ca7a0d1dd56b7",
"pubkey": "a2e99e3d68cf16b10f79060a9fa1f4da93e45f12de28dcbe7d14905668e3c479",
"created_at": 1733237949,
"kind": 1,
"tags": [
[
"proxy",
"https://mastodon.social/users/primusnews/statuses/113589482273927309",
"activitypub"
]
],
"content": "SEC Charges Kiromic BioPharma and Two Former C-Suite Executives with Misleading Investors about Status of FDA Reviews https://www.sec.gov/newsroom/press-releases/2024-189",
"sig": "a94f4941962dcb525589b08dc0794d49eaa3c8c21aa4c92e34dcaed54df8658350ccfa72089acb22df078913dc55e2f34c3de31ebe1239d5136f4bdfd4e4db3d"
}
